All the Active Ingredient Drugs
Corticosteroid, β2 Agonist. Beclometasone Dipropionate 100 mcg/metered dose, 200 mcg/metered dose, Formoterol Fumarate (dihydrate) 6 mcg/metered dose. INHALER.(pressurised sol. for inhal.):1×120 actuat.
Asthma: Maint. therapy for pts. 18 yrs. and above- 1, 2 inhal. ×2/d. max. dly. dose is 4 inhal. Maint. & reliever ther.: Pts. 18 yrs. and above- 1 inhal. ×2/d. max. dly. dose is 8 inhal.COPD: For pts. 18 yrs. and above- 2 inhal. ×2/d. See lit.
Asthma: Regular tmt. of asthma where use of a combin. product (inhaled corticost.&long-acting β2-agonist) is approp. Pts. not adequate. control. with inhal. corticoster. and ‘as needed’ inhal. rapid-act. beta2-agonist. Pts. already adequat. control. on both inhal. corticoster. and long-act. β2-agonist. COPD :Symptom. tmt. of pts. with severe COPD (FEV1 < 50% predicted normal) and a hist. of repeated exacerb., who have signific. sympt. despite regular ther. with long-act. bronchodilators.
C/I: Hypersens.
Corticosteroid/Beta 2-Agonist. Beclometasone Dipropionate 200mcg/metered dose, Formoterol Fumarate 6mcg/metered dose. INHALER. (Pressurised sol. for inhal).:1×120 actuation.
Adults 18 yrs. and above:
Two inhalations twice dly.
The max. dly. dose is 4 inhalat.
Foster 200/6 should be used as mainten. therapy only. A lower strength (Foster 100/6) is available for mainten. and reliever ther.
Indicated in the regular tmt. of asthma in adult. where use of a comb. product (inhaled corticosteroid and long-act. Β2-ag.) is appropriate:
Pts. not adequate. control. with inhaled corticosteroids and 'as needed' inhaled rapid-acting Β2-agonist.
Pts. already adequat. controlled on both inhaled corticosteroids and long-act. Β2-ag. C/I: Hypersens.
Corticosteroid. Beclometasone Dipropionate 100 mcg. AUTO HALER: 200 actuations x 50 μg,
100 μg. METERED DOSE INHALER:
50 mcg/dose; 100 mcg/dose in canister
contain. 100 or 200 actuats.
New pts: Mild asthma: 100-200 μg/day
in 2 div. doses; mod. asthma: 200-400
μg/day in 2 div. doses; severe asthma:
400-800 μg/day in 2 div. doses. Adults/
maint. dose: See lit. Transfer. pts from a
CFC-contain. inhal; dosing in
wellcontrolled pts with asthma; dosing
in poorly-controlled (symptomat.) pts
with asthma: See lit. Adults/maint.
dose: See lit. Children: > 5yrs: Mildmod.
asthma: 50 μg 2 x dly; severe: 100 μg 2
x dly. Max. dly dose: 100 μg 2 x dly.
Spacing device avail.
Proph. and tmt. bronch. asthma.
C/I: Hypersens.
Corticosteroid. Beclometasone Dipropionate 50 mcg. AUTO HALER: 200 actuations x 50 μg,
100 μg. METERED DOSE INHALER:
50 mcg/dose; 100 mcg/dose in canister
contain. 100 or 200 actuats.
New pts: Mild asthma: 100-200 μg/day
in 2 div. doses; mod. asthma: 200-400
μg/day in 2 div. doses; severe asthma:
400-800 μg/day in 2 div. doses. Adults/
maint. dose: See lit. Transfer. pts from a
CFC-contain. inhal; dosing in
wellcontrolled pts with asthma; dosing
in poorly-controlled (symptomat.) pts
with asthma: See lit. Adults/maint.
dose: See lit. Children: > 5yrs: Mildmod.
asthma: 50 μg 2 x dly; severe: 100 μg 2
x dly. Max. dly dose: 100 μg 2 x dly.
Spacing device avail.
Proph. and tmt. bronch. asthma.
C/I: Hypersens.